Prognostic Factors in the Survival Rate of colorectal cancer patients

Message:
Abstract:
Background and Objectives
colorectal cancer is The second common cancer in women and the third cancers in men. The aim of this study was to recognize of prognostic factors in the survival rate of colorectal cancer patients who referred to Omid Hospital of Mashhad from 2006 to 2011.
Material and Methods
In this historical cohort study, 241 colorectal cancer patients were investigated. Demographic and clinical data were collected. Then the prognostic factors were established by Cox model using SAS software. (α = 0.05)
Results
The mean age at diagnosis was 56.62 ± 0.94 years. The 1,2,3,4 years survival rate were 81%, 66%, 53% and 44% respectively and the Median survival time in five years period, was 3.348 years. In Cox regression model, recurrence, history of opioid consumption and Duke’s stage were determined as effective factors in the survival rate of patients. (P-value<0.05).
Conclusion
Considering different results from different studies, further studies to detection of Prognostic Factors in the survival rate of patients seem to be necessary.
Language:
Persian
Published:
Journal of North Khorasan University of Medical Sciences, Volume:7 Issue: 1, 2015
Pages:
45 to 53
magiran.com/p1417186  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!